Sheng-Bin Peng

Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers

Sheng-Bin Peng, James R. Henry, Michael D. Kaufman et al. · Cancer Cell · 2015 · 309 citations · Full text

Medicine, Cancer Biology, Oncology +16

Overexpression of G protein-coupled receptors in cancer cells: Involvement in tumor progression

Shuyu Li, Shuguang Huang, Sheng-Bin Peng · International Journal of Oncology · 2005 · 236 citations

Medicine, Molecular Biology, Oncology +16

Identification and expression of novel isoforms of human stromal cell-derived factor 1

Yu Lan, Jeffrey Cecil, Sheng-Bin Peng et al. · Gene · 2006 · 224 citations

Life Sciences, Cell Biology, Molecular Biology +5

Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma

Vipin Yadav, Xiaoyi Zhang, Jiangang Liu et al. · Journal of Biological Chemistry · 2012 · 204 citations · Full text

Medicine, Oncology, Pharmacology +15

Oncogenic <i>BRAF</i> Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120

Shih-Hsun Chen, Youyan Zhang, Robert D. Van Horn et al. · Cancer Discovery · 2016 · 172 citations

Life Sciences, Molecular Biology, Oncology +15